What Researchers Did
This report describes the case of a 61-year-old woman with pyoderma gangrenosum on both hands, detailing the multimodality treatments used for her lesions.
What They Found
The first lesion was successfully stabilized and covered using hyperbaric oxygen therapy combined with skin grafting and negative-pressure dressing. A second lesion on the other hand also achieved stabilization and resolution with intravenous and topical steroids, followed by hyperbaric oxygen therapy. The study highlights that a combination of therapies, including HBOT, can be beneficial for managing pyoderma gangrenosum.
What This Means for Canadian Patients
For Canadian patients with pyoderma gangrenosum, this case suggests that a combination of treatments, potentially including hyperbaric oxygen therapy, could be an effective approach when standard immunosuppressants alone are not sufficient. It reinforces the idea that doctors might consider HBOT as part of a broader treatment plan to help stabilize wounds and promote healing for this challenging condition.
Canadian Relevance
Although published in a Canadian journal, the study authors are not identified as Canadian, and pyoderma gangrenosum is not a Health Canada-recognized indication for hyperbaric oxygen therapy. No direct Canadian connection identified.
Study Limitations
This is a single case report, meaning its findings may not apply to all patients with pyoderma gangrenosum due to the unique nature of individual cases.